Introduction: Overview and Historical Perspective, R.O. Brady
Gaucher Disease: Molecular Biology and Genotype-Phenotype Correlations, K. S. Hruska, M. E. LaMarca, and E. Sidransky
Cell Biology and Biochemistry of Acid b-Glucosidase:
The Gaucher Disease Enzyme, G. A. Grabowski, A. Kazimierczuk, and B. Liou
Saposin C and Other Sphingolipid Activator Proteins, S. Locatelli Hoops, T. Kolter, and K. Sandhoff
The X-Ray Structure of Human Acid-b-Glucosidase:
Implications for Second-Generation Enzyme replacement therapy, L. Premkumar, I. Silman,
J. L. Sussman, and A. H. Futerman
Cellular Pathology in Gaucher Disease, A. H. Futerman
The Biochemistry and Cellular Biology of Sphingolipids and
Glucosylceramide, J. A. Shayman
The Development of Enzyme replacement therapy for Lysosomal Diseases: Gaucher Disease and Beyond, E. H. Schuchman, and S. Muro
Gaucher Disease Animal Models, Ying Sun, You-Hai Xu, and G. A. Grabowski
Type 1 Gaucher Disease - Clinical Features, P Mistry, and Ari Zimran
Neuronopathic Gaucher Disease, R. Schiffmann, and A. Vellodi,
Pathologic Anatomy of Gaucher Disease, R. E. Lee
Neuropathological Aspects of Gaucher Disease , K. Wong
Diagnosis and Laboratory Features, C.E.M. Hollak and J.M.F.G. Aerts
Imaging in Gaucher Disease, Focused on Bone Pathology, M. Maas and E.M. Akkerman
Radionuclide Evaluation of Gaucher Disease, G. Mariani and P. A. Erba
Epidemiology and Screening Policy, P.J. Meikle, M. Fuller, and J.J. Hopwood
Enzyme replacement therapy for Type I Gaucher Disease, Ari Zimran, B. Bembi, and G. Pastores
Substrate Reduction Therapy, F. M. Platt and T. M. Cox
Pharmacologic Chaperone Therapy for Lysosomal Diseases, R. J. Desnick and Jian-Qiang Fan
The Significance of the Blood-Brain Barrier for Gaucher Disease and Other Lysosomal Storage Diseases, D. J. Begley
Hematopoietic Stem Cell Transplantation, Stem Cells, and Gene Therapy, C. Peters and W. Krivit
Ethical Concerns in Treating Rare Diseases with Expensive Therapy, D. Elstein and A. Steinberg
Societal Aspects in Treating Rare Diseases with Expensive Therapy, D. Elstein, and Avi Yisraeli
Gaucher Disease as a Model for an Orphan Disease: Medical Aspects, J. Waalen, and E. Beutler
Meeting the Needs of Patients with Gaucher Disease: Pioneering a Sustainable Model for Ultra-Orphan Diseases, D. Meeker, and H. A. Termeer, Genzyme Corporation
Patients' Perspective, S. Lewis, T. Collin-Histed, J. Manuel, and G. Macres
Societal Perspective: Comment, A. Alpert, A. M. Garber, and D. P. Goldman
Gaucher Associations Around the World
Index